Internal Medicine, Rheumatology · San Francisco, CA
NPI
1174555981
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
400 Parnassus Ave # A-587
San Francisco, CA, 94143
Phone (415) 353-2497
Groups this clinician bills Medicare through
Medicare paid, 2024
$83K
3,572 services
Medicare patients, 2024
267
Average age 71
Drug cost, 2024
$2.9M
1,756 prescriptions
Company payments, 2025
$156
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew J Gross was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 376 times for 214 patients. In total Andrew J Gross billed 3,572 services in 52 codes, and Medicare paid $83K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-12-27.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 376 | 214 | $14.35 | $5,396 |
| 99215 Office E&M - Established | Facility | 212 | 120 | $118.32 | $25K |
| 99214 Office E&M - Established | Facility | 208 | 139 | $78.35 | $16K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 58 | 22 | $26.88 | $1,559 |
| 99205 Office E&M - New | Facility | 19 | 19 | $150.80 | $2,865 |
| 99204 Office E&M - New | Facility | 16 | 16 | $118.60 | $1,898 |
| 99213 Office E&M - Established | Facility | 13 | 12 | $54.35 | $707 |
| 20610 Joint Injection | Facility | 13 | 12 | $41.70 | $542 |
| 99222 Hospital E&M - Initial | Facility | 12 | 12 | $115.91 | $1,391 |
By year: 2022 $45K for 530 services; 2023 $63K for 909 services; 2024 $83K for 3,572 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrew J Gross prescribed most often to Medicare patients was Prednisone, with 219 prescriptions and refills. In total Andrew J Gross wrote 1,756 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 219 | 355 | 71 | $2,338 |
| Hydroxychloroquine Sulfate Generic | 148 | 286 | 38 | $4,925 |
| Methotrexate Methotrexate Sodium | 114 | 222 | 32 | $5,015 |
| Mycophenolate Mofetil Generic | 97 | 215 | 26 | $29K |
| Omeprazole Generic | 84 | 210 | 29 | $1,554 |
| Famotidine Generic | 58 | 125 | 19 | $848 |
| Celecoxib Generic | 54 | 84 | 13 | $1,570 |
| Enbrel Sureclick Etanercept | 52 | 59 | Under 11 | $424K |
| Mycophenolic Acid Mycophenolate Sodium | 52 | 71 | 13 | $19K |
| Alendronate Sodium Generic | 50 | 119 | 17 | $309 |
| Leflunomide Generic | 45 | 67 | Under 11 | $2,528 |
| Rasuvo Methotrexate/Pf | 39 | 53 | Under 11 | $28K |
| Pantoprazole Sodium Generic | 39 | 79 | 13 | $453 |
| Nifedipine Er Nifedipine | 38 | 50 | Under 11 | $838 |
| Actemra Tocilizumab | 33 | 33 | Under 11 | $64K |
Brand drugs: 399 claims; generic drugs: 1,357 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew J Gross $156 ($156 in general payments such as food, travel and fees) from 3 companies. The largest payer was Janssen Biotech, Inc. with $75.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.